The trend of big pharma brainpower moving to smaller firms to enable them to spend more time on innovation| Jeremy M. Levin, D.Phil, MB Bchir, CEO OF OVID THERAPEUTICS 00:10:00

Share On Facebook Share On Twitter

Jeremy Levin, D. Phil, MB BChir, is chairman and chief executive officer of Ovid Therapeutics Inc. (NASDAQ: OVID), a company whose mission is to bring treatments to patients with rare neurological conditions.

Recent Videos